We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-10.49%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$149M
AUM Growth
-$24.6M
Cap. Flow
-$790K
Cap. Flow %
-0.53%
Top 10 Hldgs %
97.09%
Holding
66
New
13
Increased
8
Reduced
17
Closed
27

Top Buys

Rank Stock Value
1
GWAV icon
Greenwave Technology Solutions
GWAV
+$2.42M
2
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$836K
3
APVO icon
Aptevo Therapeutics
APVO
+$567K
4
RVPH
REVIVA PHARMA HLDGS INC
RVPH
+$539K
5
SONN
Sonnet BioTherapeutics
SONN
+$402K

Top Sells

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$937K
2
TNXP icon
Tonix Pharmaceuticals
TNXP
+$911K
3
ELTK icon
Eltek
ELTK
+$778K
4
GMM icon
Global Mofy Metaverse
GMM
+$528K
5
RDHL
Redhill Biopharma
RDHL
+$434K

Sector Composition

Rank Sector Weight
1 Healthcare 3.47%
2 Industrials 0.4%
3 Technology 0.27%
4 Materials 0.15%
5 Financials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEXRW
51
Nexera Technologies Ltd Warrant
NEXRW
$78.7K
– –
-76,646
Closed -$4.48K
LUCYW icon
52
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$95K
– –
-103,798
Closed -$5.24K
PCSA icon
53
Processa Pharmaceuticals
PCSA
$7.2M
– –
-1,944
Closed -$115K
RCON icon
54
Recon Technology
RCON
$42.7M
– –
-157,811
Closed -$420K
RKDA icon
55
Arcadia Biosciences
RKDA
$1.4M
– –
-40,300
Closed -$89.1K
RNAZ icon
56
TransCode Therapeutics
RNAZ
$5.64M
– –
-362
Closed -$229K
RVPH
57
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
– –
-11
Closed -$81.3K
SNES icon
58
SenesTech
SNES
$7.37M
– –
-626
Closed -$4.27K
SPCB icon
59
SuperCom
SPCB
$67.3M
– –
-6,089
Closed -$20.2K
SPIR icon
60
Spire Global
SPIR
$425M
– –
-1,518
Closed -$18.2K
TC
61
TuanChe
TC
$60.8M
– –
-209
Closed -$6.44K
TNXP icon
62
Tonix Pharmaceuticals
TNXP
$157M
– –
-1,530
Closed -$911K
IVF
63
INVO Fertility Inc
IVF
$1.79M
– –
-13
Closed -$21K
SUNE
64
SUNation Energy
SUNE
$9.9M
– –
-23
Closed -$231K
FMTO
65
DELISTED
Femto Technologies Inc. Common Stock
FMTO
– –
-11
Closed -$129K
AUVI
66
DELISTED
Applied UV, Inc. Common Stock
AUVI
– –
-217,084
Closed -$323K
1 2
3

Similar funds

NA
Novus Advisors Greenville, South Carolina $44.7M AUM 18.41% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Sabby Management's Q2 2024 Portfolio in Review

As of Q2 2024, Sabby Management held 66 positions worth $149M, down 14% from $173M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Sabby Management's Q2 2024 filing shows 13 new, 8 increased, 17 reduced and 27 closed positions. Its largest new stake was Greenwave Technology Solutions: 2,086 shares worth $406K. The largest sale was Vivani Medical, an estimated $937K.

By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 5.6% a quarter earlier, followed by Industrials and Technology.

  • Sabby Management's largest Q2 2024 buy was Greenwave Technology Solutions: 2,086 shares worth $406K.
  • Sabby Management added most to Lipella Pharmaceuticals in Q2 2024, an estimated $198K increase.
  • Sabby Management's biggest Q2 2024 reduction was Vivani Medical, cutting an estimated $937K.
  • Sabby Management fully exited Tonix Pharmaceuticals in Q2 2024, selling an estimated $911K.
  • Sabby Management's ten largest holdings make up 97% of its $149M portfolio in Q2 2024.
  • Sabby Management opened 13 new positions and closed 27 in Q2 2024.
  • Sabby Management's portfolio value fell 14% quarter-over-quarter to $149M.

Based on Sabby Management's 13F filing for Q2 2024, filed 14 Aug 2024.